Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury
Brain, Behavior, and Immunity · 2026
DOI: 10.1016/j.bbi.2026.106293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2026. Verfasst von Marit Knoop und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Growth and Development, Faculty of Medicine, University of Geneva 1205 Geneva, Switzerland. Hauptthemen laut MEDLINE: Oxytocin, Brain Injuries, Traumatic, Neuroinflammatory Diseases, Neurons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gueules Cassées Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Société Française d’Anesthésie et de Réanimation.
Abstract (Originalsprache)
OBJECTIVE: Pediatric traumatic brain injury (TBI) is a leading cause of death and disability in infants, whose neurodevelopmental consequences currently lack effective treatment. Since TBI is associated with neuroinflammation, modulation of the post-injury neuroinflammatory response is a promising strategy. Oxytocin is suggested to possess anti-inflammatory properties, and seems to play a role in clinical interventions that improve brain development in neonates. However, the underlying mechanisms remain unclear, as does its applicability to acute brain injury. METHODS: Here, we assess the effects of chemogenetic activation of oxytocinergic neurons on acute neuroinflammation and on long-term brain development after TBI in postnatal day 7 (P7) male mice. Immunohistochemistry, RNA sequencing, ex-vivo MRI-diffusion tensor imaging, in-vivo functional ultrasound imaging and behavioral assays are used for assessment. Oxytocinergic neurons were chemogenetically activated daily between P7 and P10. RESULTS: We show that chemogenetic activation of oxytocinergic neurons mitigates the acute neuroinflammatory response to TBI 24 h post-injury, where it reduces the expression of inflammation-related genes, and promotes brain repair and development gene pathways in microglia. In the long-term, early-life oxytocinergic neuron activation improves subcortical and cortical white matter damage after TBI, prevents hyperactivity and loss of social behavior, and restores TBI-induced alterations in resting-state functional connectivity of the isocortex. These effects were found 35 days after the last treatment session. CONCLUSIONS: Our findings enhance the understanding of neuroinflammation modulation by oxytocin, reveal its long-term effects, and support intervention associated with endogenous oxytocin release as a promising neuroprotective strategy in pediatric TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Child Growth and Development, Faculty of Medicine, University of Geneva 1205 Geneva, Switzerland.
- Department of Child Growth and Development, Faculty of Medicine, University of Geneva 1205 Geneva, Switzerland; Center for Biomedical Imaging (CIBM), Animal Imaging Technology Section, Ecole Polytechnique Fédérale de La…
- Center for Biomedical Imaging (CIBM), University of Geneva 1205 Geneva, Switzerland.
- Laboratory animal facility, University of Geneva 1205 Geneva, Switzerland.
- Department of Basic Neuroscience, Faculty of Medicine, University of Geneva 1205 Geneva, Switzerland.
- Department of Psychiatry, University Hospital of Geneva and University of Geneva 1205 Geneva, Switzerland.
Förderung
- Gueules Cassées Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Société Française d’Anesthésie et de Réanimation
Zitieren
APA
Knoop, M., Trak, E., Possovre, M. L., van de Looij, Y., Schirmbeck, G., Ceyzériat, K., Pitetti, J. L., Sanches, E., Musardo, S., Millet, P., Tsartsalis, S., Tournier, B. B., Bellone, C., Sizonenko, S. V., Jacquens, A., & Baud, O. (2026). Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2026.106293
Vancouver
Knoop M, Trak E, Possovre ML, van de Looij Y, Schirmbeck G, Ceyzériat K, et al. Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury. Brain, Behavior, and Immunity. 2026. doi:10.1016/j.bbi.2026.106293
BibTeX
@article{Knoop2026,
author = {Knoop, Marit and Trak, Ece and Possovre, Marie-Laure and van de Looij, Yohan and Schirmbeck, Gabriel and Ceyzériat, Kelly and Pitetti, Jean-Luc and Sanches, Eduardo and Musardo, Stefano and Millet, Philippe and Tsartsalis, Stergios and Tournier, Benjamin B and Bellone, Camilla and Sizonenko, Stéphane V and Jacquens, Alice and Baud, Olivier},
title = {Chemogenetic activation of oxytocinergic neurons modulates acute neuroinflammation and improves brain development after pediatric traumatic brain injury},
journal = {Brain, Behavior, and Immunity},
year = {2026},
doi = {10.1016/j.bbi.2026.106293}
}
EUVIMED